Winner Profile
Xu Han
CEO, Realcan Pharmaceutical
Industry: Health Care Distributors
Company size: X-Large
Published: 2017-12-08
Is Realcan Pharmaceutical a good stock investment?
Based on the annual Obermatt CEO of the Year analysis, Xu Han (Realcan Pharmaceutical) earned the following Obermatt pins for the management performance.
Obermatt accolades Xu Han
| Year | Pin | Category |
|---|---|---|
| 2017 |  |
Growth Performance |
|
Operating Performance | |
 |
Combined Performance |
Xu Han was included in the competition among China Top 100 Growth Companies (China) (current winners). See the winners of the other competitions or how the CEOs performed over all competitions.
Performance Overview Xu Han
In summary, Xu Han obtained the following achievements in the individual Obermatt categories by participating in the Obermatt rankings (averages of all evaluated rankings are shown for this CEO, also for other companies):
CEO performance is displayed relative to that of other CEOs that competed in the same categories for the same number of competitions. A ranking of 71 in Combined Performance indicates that Xu Han was better than 71% of all other CEOs that were analyzed as part of the China Top 100 Growth Companies – China for one participation in Obermatt CEO competitions. Xu Han’s average ranking can be found in the Multi-Year Rankings for China Top 100 Growth Companies - China.